ResearcherSecond Affiliated Hospital of Nanchang UniversityActive in the last 2 years
Hengqing Zhu
Matched on OpenAlex author ID A5020899464. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2021: 2 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper
Papers 4
- IGF2BP3 regulates EMP1 stability in an m6A-dependent manner and activates the TGF-β pathway to promote pancreatic cancer invasion. Co-author DOI 10.1038/s41419-025-08155-1↗
- TRIM16 promotes aerobic glycolysis and pancreatic cancer metastasis by modulating the NIK-SIX1 axis in a ligase-independent manner. Co-author PMID 36504902↗
- Vaccinia-related kinase 2 drives pancreatic cancer progression by protecting Plk1 from Chfr-mediated degradation. Co-author DOI 10.1038/s41388-021-01893-4↗
- RING-finger protein 6 enhances c-Myc-mediated Warburg effect by promoting MAD1 degradation to facilitate pancreatic cancer metastasis. First author PMID 34094667↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Leifeng Chen · 2 shared papers, 2021–2022 · strength 0.28
- Yumin Qiu · 2 shared papers, 2021–2022 · strength 0.28
- Xiaogang Peng · 2 shared papers, 2021–2022 · strength 0.28
- Sheng Yan · 1 shared paper, 2025 · strength 0.22
- Xingyu Liu · 1 shared paper, 2025 · strength 0.22
- Long Liu · 1 shared paper, 2025 · strength 0.22
- Ying Huang · 1 shared paper, 2022 · strength 0.15
- Bin Zhou · 1 shared paper, 2022 · strength 0.15
- Yunyan Du · 1 shared paper, 2021 · strength 0.13
- Sisi Chen · 1 shared paper, 2021 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.